p = 0.59; EuroSCORE II, AUC 0.59; p = 0.23; STS, AUC 0.55; p = 0.52; ACEF, AUC 0.54; p = 0.69; Ambler's, AUC 0.54; p = 0.70; OBSERVANT, AUC 0.597; p = 0.21; SURTAVI, AUC 0.535; p = 0.65. SURTAVI model was calibrated best in high-risk patients showing coherence between expected and observed mortality (10.8% vs. 9.4%, p = 0.982). ACEF demonstrated best classification accuracy (17.5% vs. 6.9%, p = 0.053, respectively). Conclusions: None of the investigated risk scales proved to be optimal in predicting 30-day mortality in unselected, real-life population with aortic stenosis referred to TAVI. This data supports primary role of heart team in decision process of selecting patients for TAVI. (Cardiol J 2016; 23, 2: 169-177)